Patient Variables

PATIENT AGE SEX Hx EJECTION FRACTION BETA BLOCK CATHETERIZATION MI
        CATH ECHO SPECT   LM LAD CFX RCA (ECG)
1 53 M HTN,OSA,s/pCABGx3,s/p PTCA 30-40% FS 38.6% 76% Atenolol QD at adm 30-40% dist. 100% at orig.;faint L to L collat;R to L collat.; 100% SVG to ramus;100% SVGto D;100% SVG to LAD 50% mid distal 90% septal MI
2 70 M DM,MI(11/8/98), CHF, A-fib,HTN 58% 40-45%   Metoprolol 11/15/99 -0200 50% 70% @septal perf.;mid 70%;dist. 80%,99% ramus subtotal OM;collat. to dist. RCA &PDA dominant;100%prox.; right to distal right bridging collat. septal MI lateral MI
3 71 M CP, HTN, BPH 33%   49%     90% mid, 70% dist 90% @bifurc of OM1, OMJ1 w/50%, posterolat collat to PD & PV dominant, 100% prox Poss Q ant MI; Q inf MI
4 58 F recurr Metastatic Breast Can, HTN, depression       Metoprolol at admit DOS 40-50% distal        
5 70 M NIDDM; MI ; PVD; Hyperthyroidism 71%     Atenolol 3/1/99-0900 free of disease diffuse 50% prox and mid; dist mild irreg; D1 subtot at orig; D2 90% at orig 40-50% at orig; 60-70% prox; OM1 70-80% at orig dom. 70-80% throughout; collat from left Q inf MI
6 53 F htn, h/o IVDA, 72% > 50% 62%     100 % s/p D1, collat from CFX free of disease subtotal occl. Mid portion poss Q inf MI
7 57 M HTNX 7-8 yrs, Hx MI 36%     Atenolol QD at adm 4/5/99 (DOS 4/7) 99% mid; mild OM1 80% prox, OM2 more than 95% 100% after RV branch poss Q inf MI
8 75 M MI '78;HTN;TIA: H-chol; PUD 58%   normal; EF 61%; dimin LV compliance   50% ostial stenosis 90% LAD prox;dist & diag w/mild irreg. OM1 90% prox 80% mid; diffuse mild irreg poss Q inf MI
9 60 M Inferior MI, s/pCABGx2,RCA,Hyperlip., Unstable Angina 58%     Atenolol 0900 DOS diffuse mild to moderate dis. free of disease free of disease dominant; SVGtoPDA free; SVGtoRVA free; diffuse dis. Ostial, proximal and mid seg  
10 57 F HTN, MI 12/97 58%   35% Metoprolol BID at adm free of disease 100% after origin of D2 OM1 free of dis, OM2 90% prox, posterolateral 90% prox. Dominant, diffuse moderate to severe, 70-80% ostial, 80% mid, 90% proximal to bif Q inf MI; poss Q ant MI
11 51 F NIDDM 40%   mod diminished systolic performance EF31%     99% mid, Diagonal w/mild irreg OM1&2 free of disease small post-lat branch w/90% lesion dominant, PDA w/90% in proximal 1/3  
12 78 M       EF 61%            
13 52 F MI x ?4(inf MI 4/96),3w/arrests Vfib, Anemia, TB-tx, Arthritis,PTCA mid-RCA (4/96),OM1 & post ventricular branch (6/96) nl         80%;60% D2 70% OM1;100% OM2 90% RCA@ bifurcation Q inf MI
14 43 M CAD, s/p MIx4 '91-'94 NIDDMx2.5yrs, Hchol.;s/p PTCAx3 '91-'94         SEVERE 4 VESSEL DISEASE SEVERE 4 VESSEL DISEASE SEVERE 4 VESSEL DISEASE SEVERE 4 VESSEL DISEASE Q inf MI
15 62 M HTN;s/p PTCA RCA (96) 72%     Metoprolol 11/17/99 -2100 free of disease mid 70-80% w/aneurysm;diffuse disease mid&distal diffuse disease dominant;diffuse mild disease; patent stent  
16 72 M DM;HTN;CVA w/R hemiparesis,disarthria normal       80% distal diffuse disease up to 80%; D1 80% prox; no major disease; poss. 100% OM dominant; 80-85% orifice lesion;90% prox.  
17 78 M DMx20y, CP w/stress 49%       90% throughout mod. Disease throughout;D1 90% ost.sbtl occ. Mid;D2 95% 80% prox. Mod dis. Mid. OM1 mod Ost.; OM2 occl. Prox. consec. 80% sten. prox∣ post ventric. art. 90% lesion mid  
18 77 M IDDM, PVD, HTN 25%   decreased LV peak diast filling rate; dimin LV compliance   mild luminal irreg 100% at mid; dist fills via bridge collat;D's small w/mild irreg; coll supply dist RCA LCx w/90% prox; 80% in dist LCx involvs Ost of OM; subtotal occlus. Q inf MI; poss Q ant MI
19 80 M HTN 50% normal   Metoprolol 12/11/98   80% prox 70% prox; 50% mid; D1 80% prox 95% prox; OM1 90% 100% prox. Collat from LAD  
20 64 M Htn,IDDM 70% 64%   Metoprolol 4/30/99   3 seq prox 80-90%, diffuse one large OM w/60% prox lesion dominant, PDA w/80% mid  
21 52 M MI 10/98 47% 30-40%     free of disease 100% aft. D3; all D diffuse dis.; D3 60% sten. long 70%; OM1&2 AV Cx branch w/diffuse moderate irreg. Dominant; diffuse irreg. Several 90% sten dist; PDA diffuse dis.; Coll to LCx; PVA diffuse dis. Q inf MI
22 68 M NIDDM, periphVD,PUD 31%       40% prox 60-70%prox-mid;D1 60% prox;D2 90% prox OM1 diff.mod dis.;AV Cx 50% dist Domin;90-95% mid; dist 3rd mild irreg.;  
23 67 F HTN, MI 81(97,98?), IDDM, CVA 41%       free of disease 80% prox at D1 bif, mild irreg mid & dist OM1 90% at orig, 90% AV Cx artery Dominant, 90% mid Q inf MI
24 71 M PMH of CAD; Unstable Angina; s/p PTCA/Stent RCA 8/98 79%     Atenolol 12/7/98 -0700 normal 80-90% mjid distal; D1 prox disease; 80% prox; OM1 90% prox dominant; stent restenosis  
25 68 F HTN, Hchol,CAD, MI '93,R/I AMI 55%     Metoprolol 11/28/98 -1300 free of disease 80% prox,80% at sept branch, distal is free of disease trunk w/40% before OM1; OM&AV mild diffuse Dom; 70-80% prox to mid; diffuse disease PDA and PVA, coll from LCX Q inf MI
26 70 M DMx6y;Angina 54%         80% mid; 60% D1 D2;50% sept perf 80% 70% prox; 30% after 1st marg.  
27 58 M HTN, Hchol, Diabetes Type 1, S/p Thyroidect.,GE Reflux 40-45%     Metoprolol BID at adm 50%, 70% dist 90% mid 70% prox,80% mid 99% w/coll.from LAD Q inf MI
28 63 F MI, s/p PTCA, dyspnea on exertion, angina 5%       free of disease diffuse disease w/o sig stenosis 100% Diff irreg; coll fr. LAD  
29 69 M MI (74),Hchol,HTN, exertional angina 67%   mild decrease,de-creased compliance   subtotal occl. proximal 100% mid; OM2 100% at orig. dominant;subtotal prox,100% mid,collat.  
30 56 M HTN, COPD, OSA, NIDDM, Salmonella aortitis, CVA, MI (9/3/98),CHF,11/96 PTCA LAD 4/96 &97 37%   51%     s/p stent;diag. w/80% at ostium;50 % ramus 80% s/pOM; postlat100%;AV branch mild dominant;mod. luminal plaquing;  
31 51 M HTN, CAD, s/pPTCA of RCA w +stress test not done   normal LVSF;dimin LV compliance   50% 50% prox. near D1;diffuse irreg; D mild irreg; 90% Ramus prox dominant; 80% distal each seg; PVA diffuse irreg  
32 66 M CAD,HCB cirrhosis, NIDDM, unstable Angina 60%       nonobstruct. plaquing 100% diag.;100% mid LAD;distal collat. filling OM1 70%prox;OM2 99%prox;80% CFX @Oms;collat.from CFX to distal RCA 100% prox.;90% ostial & prox. PDA  
33 39 F IDDM, Htn, S/P KT, PVD 57% norm LVSF low normal Sys dim LV comp, EF 53% Metoprolol 05:30 DOS Dist 70% D1 70%; befSP 70%; diffuse irreg mid-dist; D1 60%; D2-D4 mild irreg 90% orig; diff irreg; collaterals from RCA dominant; free  
34 63 M CAD, HTN, NIDDM,Afib,COPD, Depression <7% mild to mod global decrease   Metoprolol BID at adm   90%; 100% D2   Dominant 100%; Collat poss Q inf MI
35 68 F NIDDM, ischemic CM, CHF 15%; LVE;   ef 15%   normal 100% prox; coll from RCA 90% prox;60% mid7distal; 90% OM1;60% OM2;normal Ramus dom.70% mid; 85% ostial of acute marg. Ant-sept MI Q inf MI
36 71 M PTCA RCA '95; AAA repair '95 65%   EF 51% ;dim LV compliance Atenolol last dose 12/13/98 (DOS 12/15) 40-50%distal 50% prox-mid;80% D2 at origin 70% mid distal mild irreg.  
37 71 M NIDDM; prostate CA 40%       LM 45-50% ostial; diffuse 50% at bifur. Of LAD & D1; 50% dist LAD; diag larger than LAD 95% dist but small vessel 100% mid; good collaterals to dist right vess from Left system Q inf MI
38 67 M HTN 53%     Metoprolol BID at adm small no focal stenosis 60% segmental prox, 50% after orig of 2nd diag branch; dist mild plaq; D1 mild plq;D2,3 small moderately large w/focal 80% in prox one-third; 30-40% through mid; dist postlat free of dis. dominant, sev dis; 90% prox, seg 80% ; 100% after orig of RVBranch;faint coll dist; LCA collat w/mod retrograde filling of distal RCA  
39 58 F CAD, HTN, IDDM, Asthma s/p CVAx2, Hchol, MI; Stent in LAD 11/97     ef 42%; mild diastolic dysfunction Metoprolol BID at adm   80% ostial dominant,80% ostial    
40 56 M CVA 1/99; Hchol, NIDDM, HTN 45-50%       mod sten ost. sev sten prox mid & distal sev prox, mod prox ramus medianus sig orificial lesion, 50% PDA w/ collat from left system  

Last Updated on 9/5/00
By Tom Smith